Ynsect Poised to Ramp Up Production of Lesser Mealworm for Human Consumption

Ynsect

PR96856

 

PARIS, July 4, 2022, /PRNewswire=KYODO JBN/--

 

EFSA has given a provisional green light for human consumption of the Lesser

mealworm in a major step forward for the insect industry

With production already underway in the Netherlands, Ynsect is now ready to

accelerate the commercialisation of its products across new European markets

Last month, 96% adults surveyed across the US, UK, France and Netherlands who

had already eaten insects or insect protein said they liked them or would try

them again

Ynsect aims to use insect protein as a solution to help tackle some of the

major challenges of our time: feeding the world's population, preserving

resources and biodiversity, and fighting global warming

 

Human insect consumption – as a nutrient-rich and efficient means to support

sustainability and meet climate change targets – has received another boost

today as the lesser mealworm (Alphitobius diaperinus) becomes the fourth insect

to receive a positive assessment by the European Food Safety Authority (EFSA)

for human consumption.

 

The EFSA assessment will have to be confirmed by the European Commission, which

will give the final authorisation for market approval in the EU following

endorsement by the EU Member States authorities, before the product can go more

widely on sale across the continent.

 

This decision comes as great news for global leader in insect farming, Ynsect,

whose Netherlands operation (formerly Protifarm) submitted the application to

EFSA with a view to expanding its activities in Europe in line with the EU's

sustainability goals. Ynsect has the infrastructure in place to expand

production and distribution immediately once the European Commission's green

light comes.

 

The race for alternative and sustainable proteins is on as the World Resources

Institute predicts a 60% gap between supply and demand for protein by 2050.

 

While insect approval for human consumption is a relatively new concept, it is

one that is already taking off in developing markets. Ynsect's other hero

protein, Molitor mealworms, were the first insect authorised by EFSA in January

2021.

 

In a survey commissioned by Ynsect and conducted OnePoll in April 2022 across

the UK, US, Netherlands and France, nearly three fifths of all respondents

(57%) revealed a willingness to consume insects once the environmental and

health benefits had been explained. Moreover, 96% of the 8,326 adults surveyed

who had already eaten insects or insect protein said they liked them or would

try them again.

 

"The recent assessment by EFSA that lesser mealworms are safe for human

consumption is a significant step forward for the company's expansion",

commented Antoine Hubert, CEO, and co-founder of Ynsect. He added: "Mealworm

protein offers the best of both worlds, as nutritionally beneficial as animal

protein, but with a much lower environmental impact. The scientific community

is increasingly rallying around the idea, with a 2022 report by the University

of Helsinki suggesting that a diet incorporating large amounts of insect

protein offers the optimum solution to reduce environmental impact by over 80%

while offering high nutritional benefits to consumers."

 

When asked if they thought (human) food manufacturers should make insect

proteins more widely incorporated into their products, over three quarters of

global survey respondents (79%) said yes, as long as it is clearly indicated on

the packaging.

 

Ynsect Human Nutrition & Health already sells ingredients using the lesser

mealworm (branded AdalbaPro) that can be found in a variety of products across

Europe, including Zirp in more han 800 Bila stores Austria, cereal bars and

Issac shakes, and gourmet burgers made from beetles found in several Danish

restaurants. The company is now on track to accelerate production to meet the

increasing demand across EU markets.

 

CONTACT: Ynsect - Anaïs Maury: anais.maury@ynsect.com / +33 (0)6 78 44 59 80

Sopexa – Rana Barbari: rbarbari@hopscotch.eu / + 353 15569720

 

SOURCE: Ynsect

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中